|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 257.51 USD | +4.22% |
|
-2.61% | +39.41% |
| 06-12 | Sector Update: Health Care Stocks Lean Lower Premarket Thursday | MT |
| 06-12 | BeOne Medicines Ltd Showcases Breakthrough Data in CLL and MCL at EHA 2025 | CI |
| Capitalization | 30.55B 26.35B 24.82B 22.57B 41.95B 2,637B 47.17B 293B 113B 1,211B 115B 112B 4,459B | P/E ratio 2025 * |
165x | P/E ratio 2026 * | 38.8x |
|---|---|---|---|---|---|
| Enterprise value | 28.47B 24.55B 23.12B 21.03B 39.09B 2,457B 43.95B 273B 105B 1,128B 107B 105B 4,155B | EV / Sales 2025 * |
5.56x | EV / Sales 2026 * | 4.52x |
| Free-Float |
96.17% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: BeOne Medicines Ltd.
More recommendations
More press releases
More news
| 1 day | +4.22% | ||
| 1 week | -4.50% | ||
| Current month | +4.86% | ||
| 1 month | +7.85% | ||
| 3 months | +2.19% | ||
| 6 months | +45.90% | ||
| Current year | +39.41% |
| 1 week | 243.35 |  | 263.88 |
| 1 month | 235.35 | | 284.51 |
| Current year | 172.67 | | 287.88 |
| 1 year | 141.31 | | 287.88 |
| 3 years | 124.46 | | 287.88 |
| 5 years | 118.18 | | 426.56 |
| 10 years | 22.51 | | 426.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Oyler
CEO | Chief Executive Officer | 56 | 2010-10-27 |
Xiao Bin Wu
PSD | President | 63 | 2018-03-31 |
Aaron Rosenberg
DFI | Director of Finance/CFO | 49 | 2024-07-21 |
| Director | Title | Age | Since |
|---|---|---|---|
John Oyler
CHM | Chairman | 56 | 2016-01-26 |
Michael Goller
BRD | Director/Board Member | 50 | 2015-03-31 |
Ranjeev Krishana
BRD | Director/Board Member | 51 | 2014-09-30 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +4.22% | -4.50% | +64.95% | +65.41% | 29.32B | ||
| +0.14% | -1.37% | +17.56% | +13.95% | 48.43B | ||
| +0.28% | -1.10% | -28.25% | -23.08% | 26.77B | ||
| -1.97% | -1.12% | -1.96% | +15.75% | 26.16B | ||
| -37.65% | +51.34% | +22,407.12% | +2,669.34% | 18.8B | ||
| +0.03% | -1.33% | +12.86% | -18.91% | 12.32B | ||
| -3.89% | -7.90% | +129.22% | - | 11.83B | ||
| +0.56% | +1.13% | -53.79% | -28.47% | 11.64B | ||
| -0.63% | +2.92% | +37.49% | +105.04% | 10.68B | ||
| -0.11% | -0.85% | +8.49% | +0.55% | 10.13B | ||
| Average | +0.21% | +12.76% | +2,259.37% | +311.06% | 20.61B | |
| Weighted average by Cap. | +0.30% | +10.93% | +2,060.80% | +273.49% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 5.12B 4.42B 4.16B 3.78B 7.03B 442B 7.9B 49.04B 18.86B 203B 19.21B 18.8B 747B | 6.2B 5.34B 5.03B 4.58B 8.51B 535B 9.57B 59.35B 22.83B 246B 23.25B 22.75B 904B |
| Net income | 129M 111M 105M 95.31M 177M 11.14B 199M 1.24B 475M 5.12B 484M 474M 18.83B | 604M 521M 491M 446M 829M 52.12B 933M 5.78B 2.23B 23.94B 2.27B 2.22B 88.15B |
| Net Debt | -2.09B -1.8B -1.69B -1.54B -2.86B -180B -3.22B -19.98B -7.69B -82.69B -7.83B -7.66B -304B | -2.55B -2.2B -2.07B -1.88B -3.5B -220B -3.93B -24.39B -9.38B -101B -9.55B -9.35B -372B |
More financial data
* Estimated data
Employees
11,000
Calendar
06-26
- R&D Day
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-06-23 | 257.51 $ | +4.22% | 450,660 |
| 25-06-20 | 247.08 $ | -2.25% | 230,772 |
| 25-06-18 | 252.78 $ | -0.52% | 230,443 |
| 25-06-17 | 254.09 $ | -3.91% | 424,802 |
Delayed Quote Nasdaq, June 23, 2025 at 04:00 pm
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
257.51USD
Average target price
331.97USD
Spread / Average Target
+28.92%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ONC Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition